Similar articles

• Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.

  Buckheit RW Jr, Fliakas-Boltz V, Yeagy-Bargo S, Weislow O, Mayers DL, Boyer PL, Hughes SH, Pan BC, Chu SH, Bader JP. Buckheit RW Jr, et al. Virology. 1995 Jun 20;210(1):186-93. doi: 10.1006/viro.1995.1330. Virology. 1995. PMID: 7540784
• A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.

  Kireev DB, Chrétien JR, Grierson DS, Monneret C. Kireev DB, et al. J Med Chem. 1997 Dec 19;40(26):4257-64. doi: 10.1021/jm970110p. J Med Chem. 1997. PMID: 9435895
• QSAR for anti-HIV activity of HEPT derivatives.

  Bazoui H, Zahouily M, Boulajaaj S, Sebti S, Zakarya D. Bazoui H, et al. SAR QSAR Environ Res. 2002 Oct;13(6):567-77. doi: 10.1080/1062936021000020035. SAR QSAR Environ Res. 2002. PMID: 12479372
• Specific HIV-1 reverse transcriptase inhibitors.

  Debyser Z, Pauwels R, Andries K, De Clercq E. Debyser Z, et al. J Enzyme Inhib. 1992;6(1):47-53. doi: 10.3109/14756369209041355. J Enzyme Inhib. 1992. PMID: 1285302 Review. No abstract available.
• HIV resistance to reverse transcriptase inhibitors.

  De Clercq E. De Clercq E. Biochem Pharmacol. 1994 Jan 20;47(2):155-69. doi: 10.1016/0006-2952(94)90001-9. Biochem Pharmacol. 1994. PMID: 7508227 Review. No abstract available.